Search research articles
Contact Us
Filters
Showing results (241-250 of 252) with videos related to
Page
of 26
Sort By:
Cancer Research Communications
|
May 9, 2025
Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
Kentaro Sawada, Riu Yamashita, Shunsuke A Sakai, et al.
JAMA Oncology
|
July 3, 2026
Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases
Kozo Kataoka, Kazuma Ito, Yoshiaki Nakamura, et al.
JCO Precision Oncology
|
February 21, 2022
Clinical Validity of Plasma-Based Genotyping for Microsatellite Instability Assessment in Advanced GI Cancers: SCRUM-Japan GOZILA Substudy
Yoshiaki Nakamura, Wataru Okamoto, Tadamichi Denda, et al.
International Journal of Clinical Oncology
|
June 17, 2019
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
Yojiro Hashiguchi, Kei Muro, Yutaka Saito, et al.
Nature Medicine
|
September 16, 2024
ctDNA-based molecular residual disease and survival in resectable colorectal cancer
Yoshiaki Nakamura, Jun Watanabe, Naoya Akazawa, et al.
Cancer Science
|
September 7, 2018
Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (Edition 1.0)
Kuniko Sunami, Hideaki Takahashi, Katsuya Tsuchihara, et al.
Nature Medicine
|
June 8, 2026
Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial
Hideaki Bando, Jun Watanabe, Yusuke Takahashi, et al.
Nature Medicine
|
October 6, 2020
Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
Yoshiaki Nakamura, Hiroya Taniguchi, Masafumi Ikeda, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 12, 2020
Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G)
Daisuke Sakai, Hiroya Taniguchi, Naotoshi Sugimoto, et al.
International Journal of Clinical Oncology
|
March 29, 2017
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
Toshiaki Watanabe, Kei Muro, Yoichi Ajioka, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 252) with videos related to
Sort By:
Page
of 26
Cancer Research Communications
|
May 9, 2025
Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
Kentaro Sawada, Riu Yamashita, Shunsuke A Sakai, et al.
JAMA Oncology
|
July 3, 2026
Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases
Kozo Kataoka, Kazuma Ito, Yoshiaki Nakamura, et al.
JCO Precision Oncology
|
February 21, 2022
Clinical Validity of Plasma-Based Genotyping for Microsatellite Instability Assessment in Advanced GI Cancers: SCRUM-Japan GOZILA Substudy
Yoshiaki Nakamura, Wataru Okamoto, Tadamichi Denda, et al.
International Journal of Clinical Oncology
|
June 17, 2019
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
Yojiro Hashiguchi, Kei Muro, Yutaka Saito, et al.
Nature Medicine
|
September 16, 2024
ctDNA-based molecular residual disease and survival in resectable colorectal cancer
Yoshiaki Nakamura, Jun Watanabe, Naoya Akazawa, et al.
Cancer Science
|
September 7, 2018
Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (Edition 1.0)
Kuniko Sunami, Hideaki Takahashi, Katsuya Tsuchihara, et al.
Nature Medicine
|
June 8, 2026
Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial
Hideaki Bando, Jun Watanabe, Yusuke Takahashi, et al.
Nature Medicine
|
October 6, 2020
Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
Yoshiaki Nakamura, Hiroya Taniguchi, Masafumi Ikeda, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 12, 2020
Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G)
Daisuke Sakai, Hiroya Taniguchi, Naotoshi Sugimoto, et al.
International Journal of Clinical Oncology
|
March 29, 2017
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
Toshiaki Watanabe, Kei Muro, Yoichi Ajioka, et al.
Page
of 26